Dunhill Financial’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.92K Buy
272
+265
+3,786% +$68.9K ﹤0.01% 925
2026
Q2
$1.75K Hold
7
– – ﹤0.01% 897
2026
Q1
$1.42K Sell
7
-2
-22% -$414 ﹤0.01% 890
2025
Q4
$1.87K Hold
9
– – ﹤0.01% 758
2025
Q3
$1.62K Hold
9
– – ﹤0.01% 723
2025
Q2
$1.46K Hold
9
– – ﹤0.01% 729
2025
Q1
$1.54K Hold
9
– – ﹤0.01% 775
2024
Q4
$1.51K Hold
9
– – ﹤0.01% 730
2024
Q3
$1.55K Hold
9
– – ﹤0.01% 752
2024
Q2
$1.39K Hold
9
– – ﹤0.01% 640
2024
Q1
$1.38K Hold
9
– – ﹤0.01% 579
2023
Q4
$1.42K Buy
+9
New +$1.29K ﹤0.01% 522

Other funds holding FBT

Dunhill Financial's FBT Position: Q3 2026 in Review

Dunhill Financial increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 3,786% in Q3 2026, buying an estimated $68.9K and bringing the position to 272 shares worth $1.92K. The position accounts for ﹤0.01% of the portfolio, ranked #925.

Dunhill Financial first reported a position in FBT in Q4 2023 and has held it in 12 quarters since. 351 funds tracked by Wall St. Rank hold FBT as of Q3 2026.

  • Dunhill Financial held 272 shares of First Trust NYSE Arca Biotechnology Index Fund worth $1.92K as of Q3 2026.
  • Dunhill Financial bought 265 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2026, an estimated $68.9K.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Dunhill Financial's portfolio in Q3 2026, its #925 holding.
  • Dunhill Financial first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2023 and has held it in 12 quarters since.
  • 351 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.

Based on Dunhill Financial's 13F filing for Q3 2026, filed 16 Nov 2026.